publication . Article . Other literature type . 2014

Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform.

Kidess, Evelyn; Heirich, Kyra; Wiggin, Matthew; Vysotskaia, Valentina; Visser, Brendan C.; Marziali, Andre; Wiedenmann, Bertram; Norton, Jeffrey A.; Lee, Mark; Jeffrey, Stefanie S.; ...
Open Access
  • Published: 10 Dec 2014 Journal: Oncotarget, volume 6, pages 2,549-2,561 (eissn: 1949-2553, Copyright policy)
  • Publisher: Impact Journals, LLC
Abstract
// Evelyn Kidess 1 , Kyra Heirich 1 , Matthew Wiggin 2 , Valentina Vysotskaia 2 , Brendan C. Visser 1 , Andre Marziali 2 , Bertram Wiedenmann 3 , Jeffrey A. Norton 1 , Mark Lee 2 , Stefanie S. Jeffrey 1 and George A. Poultsides 1 1 Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA 2 Boreal Genomics, Mountain View, CA, USA and Vancouver, BC, Canada 3 Deparment of Medicine, Division of Hepatology and Gastroenterology, Charite University Hospital, Berlin, Germany Correspondence: Stefanie S. Jeffrey, email: // George A. Poultsides, email: // Keywords : biomarker, circulating tumor DNA, colon cancer, ctDNA, hepatic metastasis Received :...
Subjects
free text keywords: Oncology, Biomarker (medicine), Cancer research, Resection, Carcinoembryonic antigen, biology.protein, biology, Colorectal cancer, medicine.disease, medicine, DNA, chemistry.chemical_compound, chemistry, Hepatology, medicine.medical_specialty, Immunology, business.industry, business, Internal medicine, Mutation, medicine.disease_cause, Polymerase chain reaction, law.invention, law, Clinical Research Paper, biomarker, circulating tumor DNA, colon cancer, ctDNA, hepatic metastasis
Related Organizations
47 references, page 1 of 4

Swarup, V, Rajeswari, MR. Circulating (cell-free) nucleic acids--a promising, non-invasive tool for early detection of several human diseases. FEBS Lett. 2007; 581: 795-799 [OpenAIRE] [PubMed]

Schwarzenbach, H, Hoon, DS, Pantel, K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011; 11: 426-437 [OpenAIRE] [PubMed]

Diehl, F, Schmidt, K, Choti, MA, Romans, K, Goodman, S, Li, M, Thornton, K, Agrawal, N, Sokoll, L, Szabo, SA, Kinzler, KW, Vogelstein, B, Diaz, LA. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008; 14: 985-990 [OpenAIRE] [PubMed]

Thierry, AR, Mouliere, F, El Messaoudi, S, Mollevi, C, Lopez-Crapez, E, Rolet, F, Gillet, B, Gongora, C, Dechelotte, P, Robert, B, Del Rio, M, Lamy, PJ, Bibeau, F. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat Med. 2014; 20: 430-435 [PubMed]

Burrell, RA, McGranahan, N, Bartek, J, Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013; 501: 338-345 [OpenAIRE] [PubMed]

Greaves, M, Maley, CC. Clonal evolution in cancer. Nature. 2012; 481: 306-313 [OpenAIRE] [PubMed]

Siegel, R, Desantis, C, Jemal, A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 104-117 [PubMed]

Van Cutsem, E, Kohne, CH, Lang, I, Folprecht, G, Nowacki, MP, Cascinu, S, Shchepotin, I, Maurel, J, Cunningham, D, Tejpar, S, Schlichting, M, Zubel, A, Celik, I. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol. 2011; 29: 2011-2019 [PubMed]

Bokemeyer, C, Bondarenko, I, Hartmann, JT, de Braud, F, Schuch, G, Zubel, A, Celik, I, Schlichting, M, Koralewski, P. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study. Ann Oncol. 2011; 22: 1535-1546 [OpenAIRE] [PubMed]

Loewenstein, MS, Zamcheck, N. Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer. 1978; 42: 1412-1418 [PubMed]

Tanaka, T, Tanaka, M, Tanaka, T, Ishigamori, R. Biomarkers for colorectal cancer. Int J Mol Sci. 2010; 11: 3209-3225 [OpenAIRE] [PubMed]

Litvka, A, Cercek, A, Segal, N, Reidy-Lagunes, D, Stadler, ZK, Yaeger, RD, Kemeny, NE, Weiser, MR, Pessin, MS, Saltz, L. False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. J Natl Compr Canc Netw. 2014; 12: 907-913 [OpenAIRE] [PubMed]

Selzner, M, Hany, TF, Wildbrett, P, McCormack, L, Kadry, Z, Clavien, PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?. Ann Surg. 2004; 240: 1027-1034 [OpenAIRE] [PubMed]

Metser, U, You, J, McSweeney, S, Freeman, M, Hendler, A. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen. AJR Am J Roentgenol. 2010; 194: 766-771 [OpenAIRE] [PubMed]

Jones, RP, Stattner, S, Sutton, P, Dunne, DF, McWhirter, D, Fenwick, SW, Malik, HZ, Poston, GJ. Controversies in the oncosurgical management of liver limited stage IV colorectal cancer. Surg Oncol. 2014; 23: 53-60 [OpenAIRE] [PubMed]

47 references, page 1 of 4
Abstract
// Evelyn Kidess 1 , Kyra Heirich 1 , Matthew Wiggin 2 , Valentina Vysotskaia 2 , Brendan C. Visser 1 , Andre Marziali 2 , Bertram Wiedenmann 3 , Jeffrey A. Norton 1 , Mark Lee 2 , Stefanie S. Jeffrey 1 and George A. Poultsides 1 1 Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA 2 Boreal Genomics, Mountain View, CA, USA and Vancouver, BC, Canada 3 Deparment of Medicine, Division of Hepatology and Gastroenterology, Charite University Hospital, Berlin, Germany Correspondence: Stefanie S. Jeffrey, email: // George A. Poultsides, email: // Keywords : biomarker, circulating tumor DNA, colon cancer, ctDNA, hepatic metastasis Received :...
Subjects
free text keywords: Oncology, Biomarker (medicine), Cancer research, Resection, Carcinoembryonic antigen, biology.protein, biology, Colorectal cancer, medicine.disease, medicine, DNA, chemistry.chemical_compound, chemistry, Hepatology, medicine.medical_specialty, Immunology, business.industry, business, Internal medicine, Mutation, medicine.disease_cause, Polymerase chain reaction, law.invention, law, Clinical Research Paper, biomarker, circulating tumor DNA, colon cancer, ctDNA, hepatic metastasis
Related Organizations
47 references, page 1 of 4

Swarup, V, Rajeswari, MR. Circulating (cell-free) nucleic acids--a promising, non-invasive tool for early detection of several human diseases. FEBS Lett. 2007; 581: 795-799 [OpenAIRE] [PubMed]

Schwarzenbach, H, Hoon, DS, Pantel, K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011; 11: 426-437 [OpenAIRE] [PubMed]

Diehl, F, Schmidt, K, Choti, MA, Romans, K, Goodman, S, Li, M, Thornton, K, Agrawal, N, Sokoll, L, Szabo, SA, Kinzler, KW, Vogelstein, B, Diaz, LA. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008; 14: 985-990 [OpenAIRE] [PubMed]

Thierry, AR, Mouliere, F, El Messaoudi, S, Mollevi, C, Lopez-Crapez, E, Rolet, F, Gillet, B, Gongora, C, Dechelotte, P, Robert, B, Del Rio, M, Lamy, PJ, Bibeau, F. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat Med. 2014; 20: 430-435 [PubMed]

Burrell, RA, McGranahan, N, Bartek, J, Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013; 501: 338-345 [OpenAIRE] [PubMed]

Greaves, M, Maley, CC. Clonal evolution in cancer. Nature. 2012; 481: 306-313 [OpenAIRE] [PubMed]

Siegel, R, Desantis, C, Jemal, A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 104-117 [PubMed]

Van Cutsem, E, Kohne, CH, Lang, I, Folprecht, G, Nowacki, MP, Cascinu, S, Shchepotin, I, Maurel, J, Cunningham, D, Tejpar, S, Schlichting, M, Zubel, A, Celik, I. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol. 2011; 29: 2011-2019 [PubMed]

Bokemeyer, C, Bondarenko, I, Hartmann, JT, de Braud, F, Schuch, G, Zubel, A, Celik, I, Schlichting, M, Koralewski, P. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study. Ann Oncol. 2011; 22: 1535-1546 [OpenAIRE] [PubMed]

Loewenstein, MS, Zamcheck, N. Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer. 1978; 42: 1412-1418 [PubMed]

Tanaka, T, Tanaka, M, Tanaka, T, Ishigamori, R. Biomarkers for colorectal cancer. Int J Mol Sci. 2010; 11: 3209-3225 [OpenAIRE] [PubMed]

Litvka, A, Cercek, A, Segal, N, Reidy-Lagunes, D, Stadler, ZK, Yaeger, RD, Kemeny, NE, Weiser, MR, Pessin, MS, Saltz, L. False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. J Natl Compr Canc Netw. 2014; 12: 907-913 [OpenAIRE] [PubMed]

Selzner, M, Hany, TF, Wildbrett, P, McCormack, L, Kadry, Z, Clavien, PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?. Ann Surg. 2004; 240: 1027-1034 [OpenAIRE] [PubMed]

Metser, U, You, J, McSweeney, S, Freeman, M, Hendler, A. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen. AJR Am J Roentgenol. 2010; 194: 766-771 [OpenAIRE] [PubMed]

Jones, RP, Stattner, S, Sutton, P, Dunne, DF, McWhirter, D, Fenwick, SW, Malik, HZ, Poston, GJ. Controversies in the oncosurgical management of liver limited stage IV colorectal cancer. Surg Oncol. 2014; 23: 53-60 [OpenAIRE] [PubMed]

47 references, page 1 of 4
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . Other literature type . 2014

Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform.

Kidess, Evelyn; Heirich, Kyra; Wiggin, Matthew; Vysotskaia, Valentina; Visser, Brendan C.; Marziali, Andre; Wiedenmann, Bertram; Norton, Jeffrey A.; Lee, Mark; Jeffrey, Stefanie S.; ...